Hairline regrowth but massive diffuse shedding
    Chat 10/4/2025

    From the encyclopedia
    Finasteride →

    Frontline, gold standard treatment for combatting androgenic alopecia

    Dutasteride →

    Heavy duty finasteride that comes with higher risks

    Minoxidil →

    An essential vasodilator with some anti-androgenic effects

    At a glance
    In this treatment experience post, the primary subjects mentioned are
    💊 Finasteride (oral) 1mg daily 6 weeks
    💊 Dutasteride (oral) 0.5mg daily 1 week
    💊 Minoxidil (oral) 1.25mg daily 1 week
    💧 Ketoconazole (topical) 2% 3x weekly 1 week
    💧 RU58841 (topical) 100mg daily 9 weeks
    the tone is 😐 neutral with some growth results.

    Other terms

    The user is experiencing diffuse shedding but also hairline regrowth after starting finasteride, switching to dutasteride, and using oral minoxidil, ketoconazole shampoo, and RU58841. Other users advise patience, suggesting that the treatments need more time to show results and caution against using too many medications simultaneously.
    View this post in the Community →

    Similar Community Posts Join

    6 / 6 results

    Related Research

    6 / 6 results
      Androgenetic Alopecia: An Update on Pathogenesis and Pharmacological Treatment

      research Androgenetic Alopecia: An Update on Pathogenesis and Pharmacological Treatment

      August 2025 in “Drug Design Development and Therapy”
      This review article examines current drugs for androgenetic alopecia, focusing on their mechanisms and clinical efficacy, noting that while finasteride and minoxidil are commonly approved treatments, new drugs targeting different pathogenic pathways have emerged, offering a broader understanding and reference for AGA treatment options.
      Antiandrogens and Androgen Inhibitors in Dermatologic Treatments

      research Antiandrogens and Androgen Inhibitors

      November 2020 in “Elsevier eBooks”
      This source outlines various antiandrogen and androgen inhibitor drugs used to treat cutaneous disorders of hyperandrogenism, detailing their mechanisms, uses, dosages, and side effects, with emphasis on spironolactone, finasteride, dutasteride, and oral contraceptives.
      Hair Loss and Herbs for Treatment

      research Hair loss and herbs for treatment

      39 citations , September 2013 in “Journal of Cosmetic Dermatology”
      This review summarizes causes and treatments of androgenetic alopecia with a focus on herbs as potential alternatives, but reports no new results and suggests more research is needed to validate these options.
      Experimental and Early Investigational Drugs for Androgenetic Alopecia

      research Experimental and early investigational drugs for androgenetic alopecia

      11 citations , July 2017 in “Expert Opinion on Investigational Drugs”
      This review discusses current and emerging therapeutic strategies for androgenetic alopecia, noting limited evidence but suggesting areas such as prostaglandin analogs, PRP, and progenitor cell therapies as promising future directions.
      Medical Therapy for Female Pattern Hair Loss

      research Medical Therapy for Female Pattern Hair Loss (FPHL)

      1 citations , May 2014 in “Hair transplant forum international”
      This commentary explores the challenges and considerations in treating female pattern hair loss, with no new clinical findings reported.